Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
Clinical trial NCT02441907 · COMPLETED
Trial details
- NCT number
- NCT02441907
- Sponsor
- Unity Health Toronto
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2018-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.